Pages that link to "Q38107168"
Jump to navigation
Jump to search
The following pages link to Diagnosis and treatment of pediatric psoriasis: current and future (Q38107168):
Displaying 10 items.
- Systemic Treatment of Pediatric Psoriasis: A Review (Q26753026) (← links)
- Adolescent Scalp Psoriasis: Update on Topical Combination Therapy (Q26800230) (← links)
- Pediatric Psoriasis (Q30234370) (← links)
- Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. (Q36552806) (← links)
- Systemic treatments in paediatric psoriasis: a systematic evidence-based update. (Q38262843) (← links)
- Pediatric psoriasis: Evolving perspectives (Q47191512) (← links)
- Psoriasis in children. (Q55006126) (← links)
- Psoriasis in childhood: effective strategies to improve treatment adherence. (Q55045498) (← links)
- Safety and efficacy of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam in adolescent patients (aged 12 to <17 years) with plaque psoriasis: results of a phase II, open-label trial (Q89780666) (← links)
- FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review (Q99581821) (← links)